Financials Neuronetics, Inc.

Equities

STIM

US64131A1051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2025-06-13 pm EDT			5-day change	1st Jan Change
3.790 ^USD	-0.52%		+1.88%	+135.40%

Jun. 10	Neuronetics Announces Clinical Presence At The 2025 Clinical TMS Society Annual Meeting And Progress In Greenbrook's Personalized Care Trial Program	RE
Jun. 02	Neuronetics Set To Join Russell 2000® And Russell 3000® Indexes	RE

Projected Income Statement: Neuronetics, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	49.24	55.31	65.21	71.35	74.5	150.3	166.3	191.3
Change	-	12.32%	17.89%	9.42%	4.42%	101.68%	10.7%	15.02%
EBITDA ¹	-21.99	-26.11	-24.72	-28.55	-21.27	-6.5	4.1	10.3
Change	-	-18.75%	5.35%	-15.5%	25.48%	69.45%	163.08%	151.22%
EBIT ¹	-22.31	-27.56	-35.11	-30.55	-34.04	-15.7	-3.933	-0.9
Change	-	-23.56%	-27.38%	12.98%	-11.41%	53.88%	74.95%	77.12%
Interest Paid ¹	-4.522	-4.019	-4.251	-5.424	-7.286	-7.794	-6.844	-5
Earnings before Tax (EBT) ¹	-27.45	-31.19	-37.16	-30.19	-43.2	-22.97	-13.29	-5.5
Change	-	-13.62%	-19.13%	18.76%	-43.11%	46.83%	42.13%	58.63%
Net income ¹	-27.45	-31.19	-37.16	-30.19	-43.2	-22.45	-10.83	-5.5
Change	-	-13.62%	-19.13%	18.76%	-43.11%	48.04%	51.76%	49.21%
Announcement Date	3/2/21	3/8/22	3/7/23	3/5/24	3/4/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales ¹	9.741	12.45	15.58	12.29	14.2	13.8	15.02	14.18	16.33	16.5	18.2	15.54	17.61	17.84	20.31	17.42	16.45	18.53	22.1	31.98	36.6	38.41	43.25	35.85	39.74	41.16	46.65
Change	-	27.79%	25.15%	-21.12%	15.58%	-2.84%	8.86%	-5.6%	15.15%	1.03%	10.3%	-14.61%	13.32%	1.33%	13.84%	-14.26%	-5.55%	12.64%	19.27%	44.68%	14.46%	4.95%	12.61%	-17.13%	10.87%	3.58%	13.32%
EBITDA ¹	-6.546	-2.209	-2.446	-6.615	-4.268	-6.942	-6.279	-7.564	-7.255	-4.889	-5.009	-7.586	-4.828	-6.517	-3.924	-4.961	-6.389	-5.797	0.108	-8.659	-0.7	-0.8	3.6	-	-	-	-
Change	-	66.25%	-10.73%	-170.44%	35.48%	-62.65%	9.55%	-20.47%	4.09%	32.61%	-2.45%	-51.45%	36.36%	-34.98%	39.79%	-26.43%	-28.78%	9.27%	101.86%	-8,117.59%	91.92%	-14.29%	550%	-	-	-	-
EBIT ¹	-6.859	-2.424	-2.66	-6.909	-6.564	-7.182	-6.908	-10.14	-9.796	-7.454	-7.726	-9.907	-7.349	-8.871	-4.427	-6.859	-8.507	-7.728	-10.95	-11.01	-3.105	-2.622	1.184	-1.797	-2.057	-1.541	-1.704
Change	-	64.66%	-9.74%	-159.74%	4.99%	-9.41%	3.82%	-46.71%	3.34%	23.91%	-3.65%	-28.23%	25.82%	-20.71%	50.1%	-54.94%	-24.03%	9.16%	-41.68%	-0.59%	71.81%	15.54%	145.15%	-251.77%	-14.47%	25.09%	-10.58%
Charge d'intérêts ¹	-0.986	-1.002	-1.011	-0.985	-0.977	-0.993	-1.064	-0.978	-1	-1.061	-1.212	-1.253	-1.144	-1.184	-1.843	-1.826	-1.978	-1.725	-1.757	-1.922	-1.961	-1.961	-1.961	-1.922	-1.922	-1.922	-1.922
Earnings before Tax (EBT) ¹	-7.765	-3.418	-3.657	-7.881	-7.525	-8.151	-7.635	-10.84	-10.42	-7.609	-8.289	-10.52	-4.901	-9.391	-5.377	-7.873	-9.832	-13.34	-12.16	-12.68	-5.016	-4.534	-0.727	-3.719	-3.979	-3.463	-3.626
Change	-	55.98%	-6.99%	-115.5%	4.52%	-8.32%	6.33%	-41.95%	3.84%	26.99%	-8.94%	-26.92%	53.41%	-91.61%	42.74%	-46.42%	-24.88%	-35.69%	8.87%	-4.25%	60.43%	9.62%	83.96%	-411.55%	-6.99%	12.97%	-4.71%
Net income ¹	-7.765	-3.418	-3.657	-7.881	-7.525	-8.151	-7.635	-10.84	-10.42	-7.609	-8.289	-10.52	-4.901	-9.391	-5.377	-7.873	-9.832	-13.34	-12.16	-12.68	-5.016	-4.534	-0.727	-3.719	-3.979	-3.463	-3.626
Change	-	55.98%	-6.99%	-115.5%	4.52%	-8.32%	6.33%	-41.95%	3.84%	26.99%	-8.94%	-26.92%	53.41%	-91.61%	42.74%	-46.42%	-24.88%	-35.69%	8.87%	-4.25%	60.43%	9.62%	83.96%	-411.55%	-6.99%	12.97%	-4.71%
Announcement Date	8/4/20	11/2/20	3/2/21	5/4/21	8/3/21	11/9/21	3/8/22	5/12/22	8/2/22	11/8/22	3/7/23	5/9/23	8/8/23	11/7/23	3/5/24	5/7/24	8/12/24	11/12/24	3/4/25	5/6/25	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Neuronetics, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Announcement Date	3/2/21	3/8/22	3/7/23	3/5/24	3/4/25	-	-	-

Estimates

Cash Flow Forecast: Neuronetics, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023	2024
CAPEX ¹	0.813	0.73	2.353	3.269	2.369	1.466
Change	-	-10.21%	222.33%	38.93%	-27.53%	-38.12%
Free Cash Flow (FCF) ¹	-15.98	-17.14	-16.04	-20.12	-20.25	-17.61
Change	-	-7.27%	6.4%	-25.45%	-0.63%	13.03%
Announcement Date	3/3/20	3/2/21	3/8/22	3/7/23	3/8/24	3/27/25

¹USD in Million

Estimates

Forecast Financial Ratios: Neuronetics, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-	-44.66%	-47.21%	-37.91%	-40.01%	-28.56%	-4.33%	2.47%	5.38%
EBIT Margin (%)	-	-45.3%	-49.83%	-53.85%	-42.82%	-45.69%	-10.45%	-2.36%	-0.47%
EBT Margin (%)	-	-55.75%	-56.39%	-56.99%	-42.31%	-57.99%	-15.29%	-7.99%	-2.88%
Net margin (%)	-	-55.75%	-56.39%	-56.99%	-42.31%	-57.99%	-14.94%	-6.51%	-2.88%
FCF margin (%)	-	-	-	-	-	-	-	-	-
FCF / Net Income (%)	-	-	-	-	-	-	-	-	-
Profitability
ROA	-15.5%	-14.34%	-15.39%	-16.71%	-15.34%	-16.54%	-	-	-
ROE	-48.86%	-74.86%	-56.37%	-52.25%	-66.17%	-132.53%	-	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	-	-	-	-	-	-	-
CAPEX / EBITDA (%)	-	-	-	-	-	-	-	-	-
CAPEX / FCF (%)	-	-	-	-	-	-	-	-	-
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Book Value Per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
EPS ¹	-	-1.46	-1.22	-1.38	-1.05	-1.37	-0.355	-0.18	-0.08
Change	-	-	16.44%	-13.11%	23.91%	-30.48%	74.09%	49.3%	55.56%
Nbr of stocks (in thousands)	-	18,975	26,368	27,221	28,933	55,652	65,820	65,820	65,820
Announcement Date	-	3/2/21	3/8/22	3/7/23	3/5/24	3/4/25	-	-	-